# Governed multi-agent roadmap

> **Planned future architecture—requires security, privacy, AI-governance, clinical-safety, legal, and operational review before implementation.**

This is planning foundation only. No agent runtime, provider, credential, production data access, autonomous merge/deploy, or user-facing agent behavior is authorized by these documents.

## Prerequisites for any phase

Named human owners and staffed escalation; approved provider/model/tool registry; agent gateway and policy enforcement; feature flags off by default; synthetic evaluation data; audit/cost controls; security/privacy/clinical/legal threat review; rollback drill; protected change process; and scoped pilot approval.

## Phase A — coordination and read-mostly controls

Chief Orchestrator, Product Coordinator, Engineering Coordinator, Security Agent, Privacy Agent, Medical Safety Agent, QA Agent, Documentation Agent, Customer Support Agent, Technology Watch Agent, and Regulatory Watch Agent. Begin with repository/public-source read and draft-only output. No user data or production mutation.

**Exit:** all roles pass validation and adversarial tests; permissions/audit/cost/kill switch are independently verified; human owners successfully operate escalation and rollback in a sandbox.

## Phase B — specialist implementation support

Backend, Frontend, Database, DevOps, Incident Response, Clinical Evidence, Pharmacy, Integrative Health, FHIR, Accessibility, Trust & Safety, and Community Moderation agents. Each remains recommendation/draft/test only; sensitive sources and domain outputs require specialist human approval.

**Exit:** dedicated domain evaluations, synthetic tenant isolation, tool failure injection, human workload/safety analysis, and scoped limited-pilot approval. No production direct writes.

## Phase C — enterprise and expansion planning

Hospital Implementation, Partnerships, Localization, Analytics, Cost Optimization, Research Governance, Global Expansion agents. These roles remain blocked until jurisdiction, partner, ethics, analytics-consent, localization, vendor and hospital requirements are known.

**Exit:** separate market/partner approvals, ethics determinations where applicable, transfer/vendor decisions, hospital IT/security evidence, accessibility/localization validation and executive risk decision.

## Explicit non-goals

No swarm autonomy, self-modifying prompts/permissions, agent-created agents, self-approval, uncontrolled persistent memory, production-data learning, medical diagnosis/prescribing, legal conclusions, policy/medical publication, automatic merges or direct production deployment.
